Thus, the ratio of CD4+/CD8+ T cells decreased following SBRT (P = 0.017), which was also observed by Yang and colleagues in patients with head and neck cancer after receiving RT (23), although the radiosensitivities of CD4+ T and CD8+ T cells have been demonstrated to be similar (24). Here, CD4 is linked to head and neck cancer.